Table 4.
EMR cohort (n=16 358) | |
---|---|
Age (mean (s.d.)) | 66.18 (15.45) |
Female (n, %) | 12 344 (75.5) |
Seropositivea (n, %) | 4470 (66.5) |
Methotrexate (n, %) | 8057 (49.3) |
Anti-TNF (n, %) | 5294 (32.4) |
% computed using available data. Anti-TNF: anti-tumour necrosis factor agents; EMR: electronic medical record.